These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21255400)

  • 21. Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?
    Marcucci G; Caligiuri MA; Bloomfield CD
    Eur J Haematol; 2003 Sep; 71(3):143-54. PubMed ID: 12930314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
    Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
    J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of CBFbeta/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics.
    Costello R; Sainty D; Lecine P; Cusenier A; Mozziconacci MJ; Arnoulet C; Maraninchi D; Gastaut JA; Imbert J; Lafage-Pochitaloff M; Gabert J
    Leukemia; 1997 May; 11(5):644-50. PubMed ID: 9180286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalized lymphadenopathy as the first presentation of granulocytic sarcoma: a diagnostic challenge.
    Elyamany G; Khan M; El Hag I; El-Zimaity M; Albalawi M; Al Abdulaaly A
    Case Rep Med; 2013; 2013():483291. PubMed ID: 24282418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
    Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
    Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
    Dissing M; Le Beau MM; Pedersen-Bjergaard J
    J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.
    Dierlamm J; Stul M; Vranckx H; Michaux L; Weghuis DE; Speleman F; Selleslag D; Kramer MH; Noens LA; Cassiman JJ; Van den Berghe H; Hagemeijer A
    Genes Chromosomes Cancer; 1998 Jun; 22(2):87-94. PubMed ID: 9598794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Core-binding factor acute myeloid leukemia.
    Sangle NA; Perkins SL
    Arch Pathol Lab Med; 2011 Nov; 135(11):1504-9. PubMed ID: 22032582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and clinical advances in core binding factor primary acute myeloid leukemia: a paradigm for translational research in malignant hematology.
    Marcucci G; Caligiuri MA; Bloomfield CD
    Cancer Invest; 2000; 18(8):768-80. PubMed ID: 11107447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
    Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
    Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge.
    Di Veroli A; Micarelli A; Cefalo M; Ceresoli E; Nasso D; Cicconi L; Mauramati S; Ottaviani F; Venditti A; Amadori S
    Case Rep Hematol; 2013; 2013():245395. PubMed ID: 24109526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature.
    Zhang XH; Zhang R; Li Y
    Leuk Res; 2010 Jul; 34(7):958-61. PubMed ID: 20116851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.
    van der Reijden BA; Martinet D; Dauwerse JG; Giles RH; Wessels JW; Beverstock GC; Smit B; Mühlematter D; Jotterand Bellomo M; Gabert J; Lafage-Pochitaloff M; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
    Leukemia; 1996 Sep; 10(9):1459-62. PubMed ID: 8751463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De Novo Acute Myeloid Leukemia with Combined
    Sethapati VR; Jabr R; Shune L; El Atrouni W; Gonzales PR; Cui W; Golem S
    Case Rep Hematol; 2020; 2020():8822670. PubMed ID: 33489389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
    Castilla LH; Bushweller JH
    Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Typical CBFbeta/MYH11 fusion due to insertion of the 3'-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22.
    Aventín A; La Starza R; Nomdedéu J; Brunet S; Sierra J; Mecucci C
    Cancer Genet Cytogenet; 2000 Dec; 123(2):137-9. PubMed ID: 11150605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
    Kim HG; Kojima K; Swindle CS; Cotta CV; Huo Y; Reddy V; Klug CA
    Blood; 2008 Feb; 111(3):1567-74. PubMed ID: 17967943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocytic sarcoma showing chromosomal changes other than the t(8;21).
    Heimann P; Vamos E; Ferster A; Sariban E
    Cancer Genet Cytogenet; 1994 May; 74(1):59-61. PubMed ID: 8194049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression.
    Xiaosu Z; Leqing C; Yazhen Q; Yu W; Xiaohui Z; Lanping X; Xiaojun H; Yingjun C
    Ann Hematol; 2019 Jan; 98(1):73-81. PubMed ID: 30159599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
    Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.